ConductScience.org, home

Trial · NCT07888790

Kinesio Taping in Young Adults With Thoracic Hyperkyphosis

NCT07888790, Not applicable, Recruiting, Istinye University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Kinesio Taping in Young Adults With Thoracic Hyperkyphosis. Trials, record NCT07888790. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07888790

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Kinesio Taping in Young Adults With Thoracic Hyperkyphosis
NCT number
NCT07888790
Status
Recruiting
Phases
Not applicable
Enrollment
40 participants, estimated
Lead sponsor
Istinye University
Conditions
Thoracic Hyperkyphosis
Interventions
Kinesiology Taping, Sham Taping
First posted
2026-10-22
Last updated
2026-10-27

Source ClinicalTrials.gov

Registered outcomes7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryThoracic Joint Position Sense4 weeks
Thoracic proprioception will be assessed using a joint position reproduction test. Participants will actively reproduce a target position corresponding to 50% of their maximum thoracic extension with their eyes closed. The absolute angular error (degrees) between the target and reproduced position will be measured using an inclinometer positioned at the T4 vertebral level. Three trials will be performed, and the mean absolute error will be recorded. Lower values indicate better proprioceptive accuracy.
PrimaryMuscle Tone4 weeks
Muscle tone will be assessed using the MyotonPRO device by measuring oscillation frequency (Hz). Measurements will be obtained from the upper trapezius, levator scapulae, sternocleidomastoid, thoracic erector spinae, pectoralis major, and pectoralis minor muscles at standardized anatomical locations.
PrimaryMuscle Stiffness4 weeks
Dynamic muscle stiffness will be assessed using the MyotonPRO device and expressed in Newtons per meter (N/m). Measurements will be performed at standardized anatomical locations in the upper trapezius, levator scapulae, sternocleidomastoid, thoracic erector spinae, pectoralis major, and pectoralis minor muscles.
PrimaryMuscle Elasticity4 weeks
Muscle elasticity will be evaluated using the MyotonPRO device through logarithmic decrement, a dimensionless parameter reflecting the dissipation of mechanical oscillations. Lower logarithmic decrement values indicate greater muscle elasticity. Measurements will be obtained from the selected cervical, thoracic, and shoulder girdle muscles.
SecondaryThoracic Kyphosis4 weeks
Thoracic kyphosis will be assessed using the Flexicurve method. The spinal curvature between C7 and T12 will be recorded in a standardized standing position, and the thoracic kyphosis angle (degrees) or kyphosis index will be calculated using standardized procedures. Lower values indicate reduced thoracic kyphosis.
SecondaryCraniovertebral Angle4 weeks
The craniovertebral angle will be measured using standardized lateral digital photographs obtained in a natural standing posture. The angle (degrees) between a horizontal line through C7 and a line connecting C7 to the tragus will be calculated. Higher values indicate improved head and cervical postural alignment.
SecondaryWall-to-Occiput Distance4 weeks
Wall-to-occiput distance will be measured in centimeters while participants stand against a wall in a standardized position, maintaining a neutral head posture. The distance between the occiput and the wall will be measured three times, and the mean value will be recorded. Lower values indicate improved sagittal postural alignment.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07888790

GET https://conductscience.org/api/trials/v1/NCT07888790/registered